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Oxide Synthase Regulate the Innate Immune
Response to a Protozoan Parasite
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of infection was dependent on the activity of NOS2 in
the tissue (Stenger et al., 1996). In contrast, during theSummary
first 5 weeks of infection, the lesion development in 129/
Sv 3 MF1 mice lacking the NOS2 gene was reported toType 2 nitric oxide synthase (NOS2) is required for the
be indistinguishable from MF1 wild-type mice, whichTh1-dependent healing of infections with intracellular
led to the conclusion that the innate response to L.microbes, including Leishmania major. Here, we dem-
major is unlikely to be associated with the NO effectoronstrate the expression and define the function of
mechanism (Wei et al., 1995).NOS2 during the innate response to L. major. At day
The type 1 interferons, a class of cytokines comprising1 of infection, genetic deletion or functional inactiva-
IFNa, IFNb, IFNv, and IFNt, are best known for theirtion of NOS2 abolished the IFNg and natural killer cell
production during viral infections and their antiviral ac-response, increased the expression of TGFb, and
tivity. Type 1 IFNs also exhibit antitumor effects, en-caused parasite spreading from the skin and lymph
hance the expression of class-1 major histocompatibilitynode to the spleen, liver, bone marrow, and lung. In-
complex molecules, stimulate the activity of natual killerduction of NOS2 was dependent on IFNa/b. Neutral-
(NK) cells, modulate the production of cytokines, andization of IFNa/b mimicked the phenotype of NOS22/2
drive the differentiation of T cells towards a Th1 pheno-mice. Thus, IFNa/b and NOS2 are critical regulators
type (Belardelli and Gresser, 1996). Both IFNa and IFNbof the innate response to L. major.
synergize with LPS for the induction of NOS2 in mouse
macrophages, but neither preparation of IFN was capa-
ble of eliciting significant amounts of NO on its ownIntroduction
(Ding et al., 1988). Although listerial, toxoplasmic, and
mycobacterial products have been described to primeProduction of nitric oxide (NO) by eukaryotic cells is
mice for the production of IFNa/b during the acute phasecatalyzed by at least three different isoforms of nitric
of infection, a critical role for IFNa/b has not been eluci-oxide synthase (NOS), which convert L-arginine and
dated in these models (Nakane et al., 1985; Havell, 1993).molecular oxygen to L-citrulline and NO or NO metabo-
In the L. major model, one study sought to establish alites (NOx). The type 2 isoform (NOS2), also known as
function of IFNa/b by using congenic C57BL/6 andinducible nitric oxide synthase (iNOS), is characterized
B6.C-H-28c mice bearing the If-1h or If-1l allele, respec-by high-output production of NO and extensive regula-
tively, but the course of infection up to day 14 wastion on the transcriptional and posttranscriptional levels
indistinguishable in these strains (Shankar et al., 1996),by various stimulatory and inhibitory cytokines. In mac-
presumably because If-1h and If-1l are inducer-specificrophages, the prototypic cell type for NOS2-dependent
loci, coding for high or low expression of IFNa/b in re-synthesis of NO, NOS2 mRNA and protein is undetect-
sponse to Newcastle-disease virus (De Maeyer-Guig-able unless the cells are activated by interferon g (IFNg)
nard et al., 1986).and/or lipopolysaccharide (LPS) (MacMicking et al.,
In the present study, we investigated the function of1997a). Expression of NOS2 by macrophages was
NOS2 and IFNa/b during the innate response toL. major.closely associated with the killing of intracellular mi-
Using mice deficient for the NOS2 gene or treated withcrobes (e.g., cryptococci, Toxoplasma, mycobacteria,
antibody to IFNa/b, we demonstrate that the expres-
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(NOS21/2) resembled wild-type mice, which demon-
strates that a single NOS2 allele is sufficient for healing
(Figures 1A±1C).
The parasite burden of the footpad lesions was re-
markably higher in NOS22/2 compared to NOS21/1 mice
from day 1 of infection onward (Figure 1E) and amounted
to a 284 (6 114)-fold increase at day 25±39 of infection
(mean 6 SEM of 5 experiments). In the respective popli-
teal lymph nodes (LNs) (Figure 1F), the parasite numbers
of NOS22/2and NOS21/1 mice differed by a factor of 22
(6 9), whereas the total LN cell number was very similar
(18 [6 3.6] 3 106 vs. 22 [6 3.8] 3 106). In the spleen,
only 2 of 8 limiting dilution analyses from 4 experiments
revealed a clear increase (.6-fold) in the number of
parasites in NOS22/2 mice within 60 or fewer days of
infection (data not shown).
Macrophages Express NOS2 at Day 1
of Infection
The differences in the parasite numbers (Figures 1E and
1F) suggested that NOS2 might be already functional
within 24 hr of infection. To demonstrate directly the
expression of NOS2 protein in L. major-infected skin, we
performed immunohistological analyses. NOS2-positive
cells were regularly found in the infiltrates of the skin 1
day postinfection, occasionally in the respective drain-Figure 1. NOS22/2 Mice Develop Nonhealing Skin Lesions after In-
ing LNs but never in the skin from naive mice, micefection with L. major
injected with PBS, or NOS22/2 mice (Figure 2A; data not(A±D) Lesion development in NOS21/1, NOS21/2, NOS22/2, and
BALB/c mice after subcutaneous infection with various doses of L. shown). As the NOS2-positive cells were focally distrib-
major promastigotes. The data in (A)±(C) and the data in (D) are from uted within the dermis of the fragile mouse skin speci-
two different experiments, representative of a total of five. mens, multiple consecutive sectionson specially coated
(E±F) Parasite burden in tissues of NOS21/1 and NOS22/2 mice at
slides were necessary for reliable detection, which ex-day 1, 25, or 43 after infection with L. major as determined by
plains our previous failures (Stenger et al., 1994). Confo-limiting dilution analysis. Significance was assumed when the 95%
cal laser microscopy revealed (1) the expression ofconfidence intervals (CI) did not overlap.
NOS2 by macrophages (F4/801) or CD11b1 (Mac-11)
cells, (2) the colocalization of L. major and macro-activity and innate cytokine production, and IFNa/b
phages, and (3) the presence of L. major in NOS2-posi-rather than IFNg is shown to be responsible for the early
tive cells. It is important to note that the majority of theinduction of NOS2.
L. major-infected cells were negative for NOS2 (Figure
2B, and data not shown). On the other hand, 50%±70%Results
of NOS2-positive cells also containedL. majorparasites.
NOS22/2 Mice Develop Nonhealing Leishmanial
Lesions Even after Low-Dose Infection
NOS2 Prevents Early Parasite SpreadingWild-type, heterozygous, or NOS2-deficient mice on a
Recently, we showed that in genetically resistant mouseresistant background (129/SvEv 3 C57BL/6), in the fol-
strains the L. major remained restricted to the site oflowing abbreviated as NOS21/1, NOS21/2, and NOS 22/2,
inoculation (footpad) and the first draining LN for 2±3were infected subcutaneously with L. major. NOS22/2
days after infection, whereas in nonhealing BALB/cmice infected with standard doses of L. major (2 3
mice, parasites disseminated to all visceral organs104 to 4 3 106) developed rapidly progressing footpad
(Laskay et al., 1995). Therefore, we tested whether para-swellings in 100% of the cases (n 5 42), which finally
site containment after 24 hr of infection with 2 3 106 L.ulcerated (Figures 1A and 1B). This was expected from
major requires NOS2 activity. NOS21/1 mice and theprevious studies using NOS inhibitors (Liew et al., 1990;
parental strains C57BL/6 and 129/Sv prevented parasiteEvans et al., 1993; Stenger et al., 1995). However, the
spreading beyond the popliteal LN. In contrast, inskin lesions in NOS22/2 mice were more severe than in
NOS22/2 mice or wild-type mice treated with the NOS2NOS21/1 mice from the very onset of their appearance
inhibitor, L-N6-iminoethyl-lysine (L-NIL) (Stenger et al.,($ day 4), which clearly contrasts with the above-men-
1995, and references therein), L. major were found intioned report by Wei et al. (1995). Furthermore, ulcerat-
the spleen, bone marrow, lungs, and liver (Figure 3A).ing lesions without any sign of regression even occurred
Furthermore, low-dose infection with L. major (500±2000when the inoculum was reduced to 100±200 parasites
parasites) led to a resistant phenotype in BALB/c mice(Figure 1C). At this parasite dose, otherwise nonheal-
but not in NOS22/2 mice (Figure 3B). Thus, NOS2 pre-ing BALB/c mice developed a curative response (Fig-
ure 1D) (Reiner and Locksley, 1995). Heterozygous mice vents parasite spreading at day 1 of infection.
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Figure 2. Immunohistological Detection of NOS2, L. major and TGFb in the Skin Lesions of NOS21/1 and NOS22/2 Mice 24 hr Postinfection
with L. major
(A) Immunoperoxidase staining of NOS2, L. major, and TGFb. Magnification, 4003; magnification for insets, 10003.
(B) Double immunofluorescence staining of NOS2 protein and L. major (confocal microscopy). (a) anti-L. major-DTAF (green). (b) anti-NOS2-
LRSC (red). (c) shows numerous L. major in NOS2-negative areas of the skin but also the presence of a L. major amastigote (yellow) in a
NOS2-positive cell (arrow). Bar, 10 mM.
NOS2 Is Indispensable for the Leishmanicidal Altered Innate Cytokine Response
in NOS22/2 MiceActivity of Macrophages
In agreement with previous studies utilizingnonselective NO has been reported to act as a signal transducer
and to modulate the cytokine production and cytotoxicNOS inhibitors (Bogdan, 1997), NOS2-deficient macro-
phages or wild-type macrophages treated with L-NIL function of macrophages or NK cells in vitro (Magrinat
et al., 1992; Cifone et al., 1994; Juretic et al., 1994;were unable to kill L. major pro- or amastigotes invitro as
assessed by three different methods (see Experimental Marcinkiewicz et al., 1995; Remick and Villarete, 1996).
Therefore, we envisaged the possibility that NOS2, inProcedures). None of the cytokine stimuli tested (IFNg,
IFNg 1 LPS, IFNg 1 TNFa, and IFNg 1 IL-2) was suffi- addition to its anti-leishmanial function, regulates the
early cytokine response and NK cell activity in vivo.cient to induce any significant antimicrobial activity in
the absence of NOS2-derived NO (Figure 3C, and data Competitive polymerase chain reaction (PCR) analysis
showed that within 1 day of infection the level of IFNgnot shown). A strikingly reduced antimicrobial activity
was also observed in vivo after intraperitoneal injection mRNA rises by a factor of 51 6 13 or 32 6 5 in the
footpad and popliteal LNs from NOS21/1 mice but onlyof 5 3 107 L. major promastigotes, when 24 hr after
infection, 40 (615)-fold more parasites were recovered by factors of 2.5 6 0.7 and 2.2 6 0.9 in the respective
tissues of NOS22/2 mice (mean 6 SEM of 3 experi-from NOS22/2 mice or L-NIL-treated wild-type mice
compared toNOS21/1 controls (mean 6 SEM of 4 exper- ments). These differences in the amounts of IFNg mRNA
were maintained until day 3, but at later time points ofiments).
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mice were infected with a 20-fold higher or a 20-fold
lower dose, respectively. The adjustment of the parasite
load, however, did not abolish the strikingly different
expression of IFNg mRNA in the LN of NOS21/1 and
NOS22/2 mice (Figure 4C, and data not shown).
When LN cells were prepared from NOS21/1 and
NOS22/2 mice at day 1 of infection and were incubated
without further stimulus, IFNg was found in 72 hr super-
natants (SNs) from NOS21/1 cultures (367, 2867, and
3250 pg/ml in 3 experiments) but not in cultures of
NOS22/2 cells. Similar results were obtained when the
cells were incubated in the presence of L. major freeze-
thaw lysates. In contrast, SNs of LN cells from uninfected
or 1 day±infected NOS21/1 and NOS22/2 mice contained
comparable quantities of IFNg after 24 hr stimulation
with the T cell mitogen concanavalin A (6.5 6 1.8 vs.
4.5 6 1.8 ng/ml, mean 6 SEM of 4 experiments). As the
production of IFNg in L. major-infected mice at day 1
and 2 is predominantly due to NK cells (Scharton and
Scott, 1993; Reiner et al., 1994), these data strongly
suggest that deletion of the NOS2 gene impairs the IFNg
release by NK cells.
When we analyzed NOS21/1 and NOS22/2 mice for
the expression of IL-12, an activator of NK cells (Biron
and Gazzinelli, 1995), we found approximately 30-fold
higher baseline levels of IL-12(p40) mRNA in the LNs of
uninfected NOS21/1 mice (Figure 4A). This ratio re-
mained roughly the same during the first 5±7 days of
infection, after which the differences vanished, and was
not altered by a 20-fold higher or lower infection dose
in NOS21/1 and NOS22/2 mice, respectively (Figure 4C).
Again, LNs of wild-type mice (or the parental strains)
treated with L-NIL exhibited IL-12 (p40) mRNA levels,Figure 3. NOS2 Is Required for the Containment of L. major In Vivo
which closely resembled those in NOS22/2 mice (Figureand for the Killing of L. major In Vitro
4B). In the footpad, the expression of IL-12(p40) mRNA(A and B) Twenty-four hours postinfection, DNA from the designated
was equally low in NOS21/1 and NOS22/2 mice and re-tissues was analyzed by PCR and 2.0% agarose gel electrophoresis
for the presence of the Leishmania-specific 120 bp fragment of mained unaltered during the first week of infection (data
minicircle kinetoplast DNA. The results shown are representative not shown). The mRNA for the IL-12(p35) subunit was
for one of three mice per group in one out of three experiments prominently expressed but not substantially modulated
performed. (A) Comparison of NOS21/1 vs. NOS22/2 mice. (B) The
in the LN and footpad of either mouse strain (data noteffect of low-dose (5 3 102) versus high-dose (2 3 106) infection on
shown). These data indicate a transient deficiency ofparasite spreading in NOS22/2 and BALB/c mice.
IL-12 in mice lacking NOS2 activity. Notably, however,(C) Macrophages were infected with a 2-fold excess of L. major
amastigotes for 5 hr. After 72 hr of stimulation with IFNg (20 ng/ml) peritoneal macrophages from NOS21/1 and NOS22/2
plus TNFa (2 ng/ml) 6 L-NIL (1 mM), NO22 in the SNs was determined mice released similar amounts of IL-12(p70) in response
(mean 6 SD), and intracellular parasites were released by SDS lysis to IFNg plus LPS (20 ng/ml each) within 17±24 hr of
and quantitated by [3H]thymidine incorporation. One of three experi-
stimulation (604 6 155 vs. 715 6 133 pg/ml, mean 6ments.
SEM of 4 experiments). Thus, IL-12 can be produced in
the absence of NOS2.
infection, the IFNg mRNA levels in NOS21/1 and NOS22/2 Two other cytokines, which are expressed at day 1
mice became indistinguishable (Figure 4A). of infection with L. major, are IL-4 and TGFb (Stenger
To rule out that the absence of the early IFNg mRNA et al., 1994; Launois et al., 1997; Scharton-Kersten and
peak in NOS22/2 mice results from strain polymorphisms Sher, 1997). In footpads and LNs from NOS21/1 and
and is unrelated to the deletion of the NOS2 gene, we NOS22/2 mice, no differences were observed in the lev-
also evaluated the IFNg mRNA expression in L. major- els of IL-4 or TGFb1 mRNA at days 1, 3, 5, 7, 14, and
infected parental inbred mice (129/Sv, C57BL/6)as com- 28 of infection (data not shown). However, by immuno-
pared to wild-type NOS21/1 (129/Sv 3 C57BL/6) mice. histology a much greater expression of TGFb protein
Figure 4B shows that the increase of IFNg mRNA 1 day was found in the skin lesions of NOS22/2 mice despite
postinfection was equivalent in all 3 groups of mice. similarly sized cellular infiltrates containing L. major par-
Treatment of these mice with L-NIL prevented the up- asites in both strains (Figure 2A).
regulation of IFNg mRNA, thus mimicking the phenotype
of NOS22/2 mice. IFNg Requires NOS2 Activity for the Down-Regulation
As the impaired IFNg response in NOS22/2 mice at of TGFb1 Production
day 1 of infection might be secondary to the increased To test whether the up-regulation of TGFb, the reduced
expression of IFNg, and the absence of NOS2 activityparasite burden in these mice, NOS21/1 and NOS22/2
Immunoregulation by IFNa/b and NOS2
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Figure 4. Altered Cytokine Responses in
NOS22/2 Mice
(A±C) IFNg and IL-12p40 mRNA expression
in the skin and in the draining LN of NOS21/1
mice, NOS22/2 mice, or in various wild-type
mice treated with the NOS inhibitor, L-NIL. In
(A) and (B), mice were infected with a stan-
dard dose of L. major (2 3 106), in (C) with
the doses indicated. Groups of three to five
mice were killed at the indicated time points,
and the cytokine mRNA levels were quanti-
tated by competitive RT-PCR of pooled RNA
preparations. One of five (A) or two (B and C)
similiar experiments.
(D) Macrophages from NOS21/1 or NOS22/2
mice were stimulated with IFNg 1 LPS (20 ng/
ml each) 6 L-NIL (1 mM) as indicated. After 72
hr SNs were harvested for NO22 determina-
tion (data not shown) or processed for the
TGFb1 ELISA. Mean (6 SEM) of 6 experi-
ments. Asterisk (*), P , 0.001 and pound sign
(#), P . 0.2 compared to untreated controls;
two asterisks (**), P , 0.002 and two pound
signs (##), P . 0.2 compared to IFNg/LPS
stimulated cells in a two-tailed paired t test).
in NOS22/2 mice were causally related, we analyzed the only slightly, indicating that the killing process itself is
not dependent on NOS2 activity (Figure 5D). FACS anal-effect of IFNg on the release of TGFb1 by macrophages.
In macrophages from CD1 mice, we recently found that ysis with a strain-selective (NK.1.1) or a pan-specific
anti-NK cell antibody (DX5) yielded similar numbers ofIFNg or IFNg/LPS inhibited the production of latent
TGFb1 protein (H. S. et al., submitted). As expected, NK cells in the LN cell preparations from NOS21/1 and
NOS22/2 mice (3.0% 6 1.3% vs. 2.8% 6 1.1% NK1.1-stimulation of NOS21/1 macrophages with IFNg/LPS re-
duced the amount of latent TGFb1 in the culture SNs positive cells, and 1.9% 6 0.4% vs. 2.0% 6 0.8% DX5-
positive cells; mean 6 SEM of 5 and 3 experiments,by 63% (6 7%) (mean 6 SEM of 6 experiments) (Figure
4D). The suppressive effect of IFNg, however, was par- respectively). Thus, NOS2 deficiency does not affect the
phenotypic development, but the functional maturationtially antagonized by cotreatment with L-NIL (30% 6
5% suppression) and was nearly absent inmacrophages of NK cells in vivo.
from NOS22/2 mice (11% 6 5% suppression). Thus,
down-regulation of TGF-b1 by IFNg requires NOS2 ac- IFNa/b Induces NOS2 and Is Expressed
in Response to L. majortivity.
Having defined several novel functions of NOS2, we
undertook experiments to identify the cytokine respon-Impaired NK Cell Cytotoxic Activity
in NOS22/2 Mice sible for its expression after 24 hr of infection. Unexpect-
edly, NOS2 protein was induced to a similar degree inThe lack of IFNg at day 1 of infection in NOS22/2 mice
led us to analyze whether the deletion of NOS2 also NOS21/1 mice treated with anti-IFNg in C57BL/6 mice
genetically deficient for the IFNg gene and in untreatedaffects the cytotoxic function of NK cells. Indeed, LN
cells from infected NOS22/2 mice exhibited a markedly wild-type or C57BL/6 control mice (Figure 6A, and data
not shown). In contrast, application of anti-IFNa/b re-reduced NK cell cytotoxicity when compared to wild-
type mice or the parental strains (Figures 5A and 5B). duced the number of NOS2-positive cells in the skin of
NOS21/1 mice by greater than 90% as compared to miceIn NOS22/2 mice, the NK cell cytotoxicity was not re-
stored by lowering the parasite inoculum from 2 3 106 treated with a control immunoglobulin (8 vs. 131 NOS2-
positive cells on 196 vs. 208 skin sections from 5 experi-to 1 3 105, and in NOS21/1 mice, it was increased rather
than decreased after injection of a 20-fold higher dose ments) (Figure 6A). Similar results were obtained with
IFNg2/2 mice (data not shown). In vitro, L. major togetherof L. major (Figure 5C). In vivo treatment of NOS21/1
mice with L-NIL decreased the specific cytotoxicity to with a combination of IFNa plus IFNb (10±100 U/ml each)
but not promastigotes or the type 1 interferons alonethe levels obtained with NOS22/2 cells (Figure 5B). In
contrast, in vitro addition of L-NIL to the cocultures of activated NOS21/1 macrophages for the production of
NO. This was also observed with macrophages fromLN and targets cells reduced the specific target cell lysis
Immunity
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mRNA peak in the LN of NOS21/1 mice. IFNa/b but
not a control preparation from the IFNa/b purification
markedly enhanced the NK cell cytotoxic activity and
the expression of IFNg mRNA in NOS21/1 wild-type or
BALB/c mice after 24 hr of infection. No such effect was
observed in NOS22/2 mice or in BALB/c mice treated
with L-NIL (Figures 7B and 7C, and data not shown).
Taken together, L. major-induced IFNa/b mediates key
events of the innate response to L. major (parasite con-
tainment, IFNg expression, NK cell cytotoxic activity) via
induction of NOS2.
Discussion
Macrophages, IL-12, and NK cells are established com-
ponents of the innate response of the host immune sys-
tem against a variety of microbial pathogens, including
Listeria, Toxoplasma, and Leishmania (Biron and Gazzi-Figure 5. NOS2 Activity In Vivo Is Required for the Generation of
nelli, 1995; Scharton-Kersten and Sher, 1997). In thisNK Cell Cytotoxicity in Response to L. major Infection
paper, we provide direct evidence that type 1 interferonsNK cell cytotoxic activity of LN cells (A) from uninfected or day
and the inducible isoform of nitric oxide synthase (iNOS,1-infected (2 3 106) NOS22/2 mice, NOS21/1 mice, or NOS21/1 mice
treated with L-NIL in vivo; (B) from day 1-infected (2 3 106) 129/ NOS2) are tied into the early defense machinery of the
SvEv, C57BL/6, and NOS21/1 mice with or without in vivo treatment host and exert functions, which can be readily observed
with L-NIL as compared to the activity of NOS22/2 cells; or (C) from on day 1 of infection with L. major. Specifically, we
NOS21/1 versus NOS22/2 mice infected with different doses of L.
demonstrate that IFNa/b is induced by L. major in vitromajor. (D) Effect of the presence of L-NIL during the assay (in vitro)
and in vivo and is required for the initial expressionon the NK cell cytotoxicity of LN cells from day 1-infected (2 3 106)
of NOS2. NOS2, in turn, is shown to be a molecularNOS21/1 mice as compared to prior in vivo treatment with L-NIL.
prerequisite for early parasite containment, which we
previously identified as a typical phenotype of self-heal-IFNg2/2 mice, indicating that the IFNa/b-induced pro-
ing, genetically resistant mouse strains (Laskay et al.,duction of NO was independent of endogenous IFNg
1995). In addition, NOS2-derived NO is essential for an(Figure 6B). Furthermore, NOS21/1 or NOS22/2 macro-
elevated baseline expression of IL-12(p40), for mountingphages exposed to L. major promastigotes produced
the early IFNg response, the maturation of functionalIFNa/b (Figure 6D). IFNa/b was also detected in the
NK cells, and the suppression of TGFb1, which pointsskin of infected mice by immunohistology, but not if the
to a immunoregulatory function of NO in vivo. Our obser-primary antibody was preabsorbed with IFNa/b (Figure
vation that depletion of IFNa/b abolishes the expression6C). No IFNa/b was found in the skin of naive mice (data
of NOS2 at day 1 of infection and mimics the alterednot shown). These data strongly suggest that L. major
cytokine and NK cell response in NOS22/2 mice is thetriggers the production of IFNa/b and both together in-
first demonstration of a function of IFNa/b during theduce the expression of NOS2.
innate response to a nonviral pathogen.
Treatment of NOS21/1 Mice with Anti-IFNa/b
Mimics the Defects of the Innate Response NOS2 and Early Parasite Containment
Using a highly sensitive PCR technique for the detectionObserved in NOS22/2 Mice
To corroborate the causal relationship between the in- of Leishmania, we show that NOS2 activity prevents the
dissemination of L. major parasites on day 1 of infection.duction of IFNa/b, the expression of NOS2, and the
innate immune response, we finally tested whether neu- For several reasons this finding is unlikely to represent
only a novel facet of the previously recognized leishman-tralization of IFNa/b leads to the same phenotype as the
genetic deletion of NOS2. In addition, we investigated icidal activity of NO. First, parasite spreading still oc-
curred when the dose of infection was lowered from 2 3whether the activity of exogenously applied IFNa/b is
dependent on endogenous NOS2. NOS21/1 mice treated 106 to 500. Considering that 24 hr after infection with a
standard dose of L. major (2 3 106) the number of para-with antibody to IFNa/b (and thereby deficient for
NOS2) were unable to prevent early parasite spreading. sites in the footpad or LN of NOS22/2 mice is only ap-
proximately 10- to 20-fold higher than in NOS21/1 mice,BALB/c mice treated with IFNa/b acquired the resistant
phenotype (parasite containment) but not after simulta- a reduction of the infection inoculum to 500 parasites
(i.e., by a factor of 4000) should lead to parasite contain-neous application of the NOS2 inhibitor, L-NIL. Likewise,
IFNa/b treatment did not prevent parasite spreading in ment if NO solely functioned as a leishmanicidal effector
molecule. Second, our immunohistological analysis re-NOS2-deficient mice (Figure 7A). In IFNg2/2 mice para-
site spreading occurred despite the expression of NOS2 vealed that NOS2 is focally expressed in the skin and
that the majority of L. major-infected cells were negativeand was not prevented by IFNa/b treatment (Figures 6A
and 7A). for NOS2. Third, as parasite spreading was also ob-
served in anti-IFNg-treated mice (Laskay et al., 1995) orApplication of anti-IFNa/b drastically reduced the NK
cell cytotoxic activity and abolished the early IFNg IFNg2/2 mice (Figure 7A) despite the expression of
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Figure 6. IFNa/b Induces NOS2 and Is Expressed in Response to L. major
(A) Immunoperoxidase staining of NOS2 at day 1 of infection in the lesional skin of C57BL/6 IFNg2/2 mice, C57BL/6 IFNg1/1 mice, NOS21/1
mice treated with antibody to IFNa/b, and NOS21/1 mice treated with control immunoglobulin (Ig). Magnification, 4003; magnification for
insets, 10003.
(B) Macrophages from NOS21/1 or IFNg2/2 mice were stimulated with L. major promastigotes (ratio 1:1), IFNg (20 ng/ml), IFNa plus IFNb (50
U/ml each), or combinations thereof. Triplicate SNs were assayed for NO22 after 48 hr. The anti-IFNa/b Ig was used at 1000 neutralizing U/ml.
One of four experiments.
(C) Immunoperoxidase staining of IFNa/b in NOS21/1 mice 24 hr postinfection with L. major (arrow). The IFNa/b staining was blocked by
preabsorption of the primary antibody with IFNa/b. Magnification, 4003; magnification for insets, 10003.
(D) SNs from cultures of NOS21/1 macrophages after 24 hr of stimulation with an equal number of L. major promastigotes (or 20 mg/ml poly
I:C as a positive control) were assayed for the IFNa/b content in the L929/VSV assay in the absence or presence of anti-IFNa/b Ig (5000
neutralizing U/ml). One of three experiments.
NOS2, the IFNa/b-induced and NOS2-dependent early production of IFNg. We found that the NK cytotoxicity
IFNg response and not NO itself appears to mediate the of LN cells from L. major-infected mice toward tumor
process(es) leading to parasite containment. Thus, we targets was independent of NOS2 activity, whereas the
believe that parasite containment primarily reflects a functional maturation of these cells in vivo was clearly
novel regulatory function of NO (e.g., on the migration dependent on NOS2. To our knowledge, this is the first
and adhesion of L. major-infected cells) rather than a report that NO (NOS2) is a prerequisite for the develop-
direct leishmanicidal effect of NO. It is possible that in ment of NK cytotoxicity in vivo.
the presence of NOS2 and IFNg, L. major-infected cells
are retained in the first draining LN, whereas in the ab-
sence of NOS2, the signals required for the retention of NOS2 and the Innate Cytokine Response
the cells immigrating from the skin via the afferent lymph Whereas NO has been recognized earlier as an antimi-
are missing. crobial molecule of the T cell±independent natural resis-
tance toward other intracellular pathogens (Beckerman
NOS2 and NK Cell Activity
et al., 1993; MacMicking et al., 1997b), regulation of thePrevious studies with rat peripheral blood lymphocytes
innate cytokine response by NO has not been demon-suggested that NO functions as a cytotoxic effector
strated before in any infectious disease model. Severalmolecule of NK cells and is also required for the genera-
of our findings strongly argue for the concept that thetion of lymphokine-activated killer cells by IL-2 in vitro,
defective expression of cytokines and the impaired NKbut they did not define the underlying NOS isoform (Ci-
cell activity in NOS22/2 mice on day 1 postinfectionfone et al., 1994; Juretic et al., 1994). On the other hand,
directly result from the lack of NO and are not due toBeckerman et al. (1993) reported that killer cells pre-
the increased parasite burden seen in these mice. First,pared from mouse bone marrow cells by repetitive cul-
ture in IL-2 did not produce NO when stimulated for the the drastically reduced expression of IL-12(p40) mRNA
Immunity
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Figure 7. IFNa/b Regulates the Innate Response to L. major
(A) Analysis of parasite spreading by PCR detection of L. major DNA (see Figure 3A and 3B legends) in the tissues of NOS21/1, NOS22/2,
BALB/c, or IFNg2/2 mice treated with IFNa/b or anti-IFNa/b or the respective controls. One of four experiments.
(B) NK cytotoxicity of LN cells from day 1-infected mice treated with anti-IFNa/b, IFNa/b or the respective controls, and L-NIL. One of three
experiments.
(C) Effect of treatment with anti-IFNa/b or IFNa/b on the expression of IFNg mRNA in the LNs of NOS21/1 or NOS22/2 mice as determined
by competitive PCR.
was already seen in uninfected NOS22/2 or L-NIL- the absence of NOS2 and from the deficiency of IFNg.
As TGFb inhibits the activity of NK cells (Rook et al.,treated NOS21/1 mice (Figure 4A). Second, the pheno-
type of NOS21/1 and NOS22/2 mice was not reverted 1986; Scharton-Kersten and Sher, 1997), the enhanced
expression of TGFb might further promote the pheno-when the tissue parasite loads were adjusted to each
other by injection of a 20-fold higher or lower number of type observed in NOS22/2 mice.
promastigotes, respectively (Figures 4C and 5C). Third,
after day 7 of infection, the IL-12(p40) or IFNg mRNA Interaction of Innate and Adaptive
Immune Responselevels in NOS21/1 and NOS22/2 mice became indistin-
guishable, although the numbers of parasites per organ Although NOS2 is required for the generation of func-
tional NK cells and the innate production of IFNg, thecontinued to be strikingly different in the two mouse
strains (Figure 4A). expression of IFNg mRNA in NOS22/2 mice reached or
even exceeded wild-type levels at late time points ofOne obvious question is whether the reduced baseline
levels of IL-12(p40), the delayed up-regulation of IFNg, infection (Figure 4A and Wei et al., 1995). This finding
is in line with the development of Th1 cells and thethe enhanced expression of TGFb, and the impaired NK
cell cytotoxic activity in NOS22/2 mice are parallel, but ultimate curative phenotype in resistant mice even in
the absence of NK cells (Laskay et al., 1993; Schartonindependent, or causally linked consequences of the
lack of NO. Earlier studies showed that NK cells are and Scott, 1993). However, considering the established
interactions between the innate and the adaptive im-largely responsible for the production of IFNg in the LN
of L. major-infected mice at day 1 and 2 of infection mune system, the question arises why the severely im-
paired innate response in NOS22/2 mice does not obvi-(Scharton and Scott, 1993; Reiner et al., 1994). As NK
cells are activated by IL-12, the reduced baseline ex- ate the emergence of CD41 IFNg-producing T cells as
recently reported for mice lacking the interferon regula-pression of IL-12(p40) in NOS22/2 mice is likely to con-
tribute to the diminished early IFNg production and NK tory factor 1 (IRF-1). IRF-12/2 mice exhibit a strikingly
reduced NK cell function and number, a severely com-cell cytotoxic activity. In addition, we have preliminary
evidence that at day 1 of infection the responsiveness promised production of IL-12 (in response to IFNg/LPS),
and a lack of Th1 cells (Duncan et al., 1996; Lohoff etof mice to exogenous IL-12 in vivo and of LN cells from
infected mice in vitro are markedly reduced if not miss- al., 1997; Taki et al., 1997). As IRF-1 regulates the activity
of the IFNa and IFNb promotor, the expression of NOS2,ing in the absence of NOS2 activity (A. D. et al., unpub-
lished data). The hyperexpression of TGFb presumably as well as several other IFN-inducible genes (Reis et
al., 1992; Martin et al., 1994), it remained unresolvedresults from the impaired suppressive effect of IFNg in
Immunoregulation by IFNa/b and NOS2
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Antibodieswhether IRF-1 directly affects the production of IL-12
The human or rabbit antiserum against L. major, mouse NOS2-and the generation of NK cell activity or indirectly via
peptide, or against TGFb were the same as used before (Stengeranother mediator such as NO. Our results with NOS22/2
et al., 1996). The rat mAbs M1/70.15 (Mac-1) and C1. A.3-1 (F4/
mice indicate that the reduction of NK cell activity in 80) were from Dianova (Hamburg, Germany). Phycoerythrin-labeled
IRF-12/2 mice in vivo might be due to the absence of anti-NK1.1 and FITC-conjugated anti-mouse Pan-NK cells (DX5)
were from Pharmingen (Hamburg, Germany).NOS2. In contrast, the IFNg-induced production of IL-
12, which is defective in IRF-12/2 macrophages, is unal-
tered in NOS22/2 macrophages and therefore appears DNA Preparation and PCR for the Detection
of Leishmanial DNAto be independent of endogenous NO. Thus, IL-12 be-
DNA was isolated from tissues using InstaGene (Biorad, Munich,comes available and a Th1 response will finally develop
Germany). A Leishmania-specific 120 bp fragment of minicircle ki-in NOS22/2 mice but not in IRF-12/2 mice.
netoplast DNA was amplified by PCR strictly following ourpreviously
In conclusion, we have identified IFNa/b as a potent established protocols. Detection of leishmanial DNA originates from
inducer of NOS2 in vivo and as a key regulator of the live parasites and not from parasite debris (Laskay et al., 1995).
innate immune response to the protozoan parasite L.
major. Our results point to a dual function of NO during RNA Preparation, cDNA Synthesis, and
the early and late phase of infection. During the innate Reverse Transcriptase-PCR
phase (day 1 and day 2), focally expressed NOS2 con- RNA was extracted from frozen tissue by the guanidinium-isothiocy-
anate method, reverse-transcribed, and quantitated by competitivetrols the activity of NK cells, the early cytokine response,
reverse transcriptase-PCR (Stenger et al., 1994). The competitorand parasite spreading. During the late phase, NOS2 is
plasmids were as follows: (1) piNOSL1(HincII162 bp) (Stenger et al.,further up-regulated by IFNg-producing CD41 T lympho-
1994); (2) pNIL (IL-12p35, IL-12 p40) (Kopf et al., 1996); (3) pMCQ
cytes, and its antimicrobial activity is likely to predomi- (b-actin, IL-4, and IFNg) (Platzer et al., 1992); (4) pTGFb1COMP. The
nate. The latter process is critical for the reduction of latter competitor was generated from the originalcDNA by the linker-
the parasite burden and hence for the clinical resolution primer technique (FoÈ rster, 1994) and was used with the following
primers: TGFb1 sense 59-CTCCCACTCCCGTGGCTTCTA-39 (bp po-of the disease.
sition 389→409 of the mouse TGFb1 sequence (Derynck et al., 1986)
and TGFb1 antisense (bp position 1055→1035 59-CCACGTGGAGTT
Experimental Procedures TGTTATCTT-39). All other primer sequences were as published for
the competitors. The annealing temperatures were 588C (NOS2,
Mice TGFb1, and IL-12p40) or 608C (IL-4, IFNg, and b-actin). The number
Breeding pairs of (129/SvEv 3 C57BL/6) mice with a disrupted NOS2 of PCR cycles was 35 except for b-actin (28 cycles).
gene (NOS22/2) (MacMicking et al., 1997b) and wild-type controls
(NOS21/1) were provided by C. Nathan (New York) and J. Mudgett
Cell Culture and Leishmanicidal Assays(Merck, Rahway, NJ). The NOS21/1, NOS21/2, and NOS22/2 mice
All cells were cultured in RPMI1640 (supplemented as describedused here were obtained from homozygous or heterozygous inter-
(Stenger et al., 1996) with 10% fetal bovine serum (LN cells), 2.5%crosses in the F6 to F8 generation (129/SvEv 3 C57BL/6). Breeding
fetal bovine serum (macrophages), or without serum (macrophagepairs of C57BL/6 mice deficient for the IFNg gene (IFNg2/2) were
culture for TGFb production). Used stimuli were LPS (O111:B4),provided by M. Kopf (Basel Institute for Immunology, Switzerland).
freeze-thaw lysates of L. major promastigotes, rmIFNg (Ernst Boeh-C57BL/6 and 129/Sv mice were from Charles River (Sulzfeld, Ger-
ringer Institut, Vienna, Austria), rmTNFa (Genzyme, Boston, MA),many) and Harlan-Winkelmann (Borchen, Germany). All mice were
purified mouse IFNa (NIAID Repository, Rockville, MD), purifiedused at 6±12 weeks and were age- and sex-matched.
mouse IFNb (NIAID Repository), sheep-anti-mouse IFNa/b (neu-
tralizing titer 1:300,000 against 8±10 units of IFNa/b), and sheep
L. major Infection control serum (NIAID Repository). At the concentrations used, the
Origin and propagation of the L. major strain were as reported LPS content of all reagents was less than 10 pg/ml as determined
(Stenger et al., 1996). Unless otherwise stated, mice were infected with a colorimetric assay (Whittaker Bioproducts, Walkersville, MD).
in the left hind footpad with 2 3 106 stationary-phase L. major pro- Thioglycollate-elicited peritoneal cells and adherent macrophage
mastigotes in 30±50 ml phosphate-buffered saline (PBS) or in 10 ml monolayers were prepared and cultured as published (Stenger et
PBS for immunohistological analyses. Footpad swelling was mea- al., 1995).
sured with a metric caliper. The number of parasites in the tissue For leishmanicidal assays, macrophage monolayers were treated
was determined by limiting dilution applying Poisson statistics and with cytokines for 10±22 hr prior to infection with a 3- to 10-fold
the x2-minimization method (Stenger et al., 1996). excess of L. major pro- or amastigotes (Bogdan et al., 1991). After
3±7 hr, nonphagocytosed parasites were washed off, and the cul-
In Vivo Treatment of Mice tures were further incubated in the respective medium (4±72 hr). The
L-N6-iminoethyl-lysine (L-NIL) (Searle, St. Louis, MO) was applied number of intracellular parasites was determined by fluorescence
orally in acidified (pH 2.7) drinking water (5±10 mM) and by intraperi- microscopy, by incorporation of [3H]thymidine into released para-
toneal injection (2.5±5 mg in 0.5 ml PBS twice daily), starting 2±4 sites after SDS lysis of the macrophages, or by culturing of the
days prior to infection. Anti-mouse IFNg (affinity-purified rat mAb macrophage lysates in modified Schneider's medium under limiting
XMG1.2) was injected intraperitoneally (250 mg in 0.5 ml) at days dilution conditions (Bogdan et al., 1991).
21 and 0 of infection and into the footpadtogether with the parasites
(2 3 106 L. major in 10 ml PBS with 7±10 mg XMG1.2). Partially
Determination of NK Cell Cytotoxicity
purified natural mouse IFNa/b (Gresser et al., 1988, 1.2±1.6 3 107
NK cytotoxic activity of draining LN was measured against 51Cr-
U/ml, specific activity 2 3 107 U/mg) or a control preparation from
labeled YAC-1 targets in a 4 hr chromium release assay (Laskay et
the purification (,50 U/ml) was injected intraperitoneally (0.2 ml)
al., 1993). Spontaneous release never exceeded 10%±15% of the3±4 hr prior to infection and into the footpad together with the
maximal release.parasites (2 3 106 L. major in 10 or 50 ml of the IFNa/b or control
preparation). The same protocol was chosen for the sheep-anti-
mouse IFNa/b immunoglobulin (Gresser et al., 1988 ; $1 3 106 Cytokine Measurements
For the determination of TGFb1 by ELISA, serum-free macrophageneutralizing U/ml against 4 units of IFNa/b) and the control sheep
immunoglobulin (generated against the impurities of the IFNa/b SNs were acid-activated and processed as described (Danielpour,
1993). The mAb 12H5 (Noble et al., 1993) (Genentech, South Sanpreparation or purified from normal sheep serum).
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Francisco, CA), which only binds active TGFb1, was used for captur- Cytokine interactions in experimental cutaneous leishmaniasis: in-
terleukin 4 synergizes with interferon-g to activate murine macro-ing, and a chicken-anti-TGFb1 antibody (R & D Systems, Minneapo-
phages for killing of Leishmania major amastigotes. Eur. J. Immunol.lis, MN) followed by peroxidase-conjugated rabbit-anti-chicken IgY
21, 327±333.antibody (Dianova, Hamburg, Germany) was used for detection. The
ELISA had a detection limit of approximately 78 pg/ml. Cifone, M.G., Festuccia, C., Cironi, L., Cavallo, G., Chessa, M.A.,
Mouse IL-12 (p70 heterodimer) was determined by capture ELISA Pensa, V., Tubaro, E., and Santoni, A. (1994). Induction of the nitric
(Pharmingen) with a lower detection limit of 156 pg/ml. The capture oxide-synthesizing pathway in fresh and interleukin-2 cultured rat
ELISA for measuring IFNg was performed as described (Laskay et natural killer cells. Cell. Immunol. 157, 181±194.
al., 1993) and had a detection limit of 39±78 pg/ml. Danielpour, D. (1993). Improved sandwich enzyme-linked immuno-
The IFNa/b content of macrophage SNs (24 hr) was determined sorbent assays for transforming growth factor-b1. J. Immunol. Meth.
with a bioassay using L929 fibroblasts and vesicular stomatitis virus 158, 17±25.
(VSV) as described (Havell, 1993). A neutralizing sheep-anti-IFNa/b De Maeyer-Guignard, J., Dandoy, F., Bailey, D.W., and De Maeyer, E.
antiserum was used to ascertain that all antiviral activity in the SNs (1986). Interferon structural genes do not participate in quantitative
was due to IFNa/b. regulation of interferon production by If loci as shown in C57BL/6
mice that are congenic with BALB/c mice at the alpha interferon
gene cluster. J. Virol. 58, 743±747.Determination of Nitrite Accumulation
NO22 in culture SNs was determined by the Griess assay (Stenger Derynck, R., Jarrett, J.A., Chen, E.Y., and Goeddel, D.V. (1986). The
et al., 1994). murine transforming growth factor-b precursor. J. Biol. Chem. 261,
4377±4379.
Ding, A.H., Nathan, C.F., and Stuehr, D.J. (1988). Release of reactiveImmunohistology
nitrogen intermediates and reactive oxygen intermediates fromCryostat tissue sections (5 mM) were thawed onto slides coated
mouse peritoneal macrophages: comparison of activating cytokineswith Fro-Marker (Electron Microscopy Sciences, Ft. Washington,
and evidence for independent production. J. Immunol. 141, 2407±PA), air-dried, and fixed in acetone. Immunoperoxidase staining
2412.using 3-amino-9-ethyl-carbazole as a substrate and hematoxylin
as counterstain was performed as before (Stenger et al., 1994). Duncan, G.S., MittruÈ cker, H.-W., KaÈ gi, D., Matsuyama, T., and Mak,
T.W. (1996). The transcription factor interferon regulatory factor-1All secondary antibodies were affinity-purified biotin-conjugated
is essential for natural killer cell function in vivo. J. Exp. Med. 184,F(ab9)2 fragments from Dianova (Hamburg).
2043±2048.
Evans, T.G., Thai, L., Granger, D.L., and Hibbs, J.B., Jr. (1993). EffectConfocal Microscopy
of in vivo inhibition of nitric oxide production in murine leishmaniasis.For double immunoflorescence staining, fixed cryostat sections
J. Immunol. 151, 907±915.were blocked with PBS/1% bovine serum albumin/1% saponin, in-
FoÈ rster, E. (1994). An improved general method to generate internalcubated sequentially with human anti-L. major serum (or rat mAb
standards for competitive PCR. Biotechniques 16, 18±20.anti-cell-type), fluorescein(DTAF)-conjugated goat-anti-human (or
donkey-anti-rat) IgG F(ab9)2 fragments, rabbit-anti-mouse-NOS2 (or Gresser, I., Maury, C., Vignaux, F., Haller, O., Belardelli, F., and
rabbit-anti-L. major), and lissamine-rhodamine(LRSC)-conjugated Tovey, M.G. (1988). Antibody to mouse interferon a/b abrogates
donkey-anti-rabbit IgG F(ab9)2 fragments, and finally mounted with resistance to the multiplication of Friend erythroleukemia cells in
the livers of allogeneic mice. J. Exp. Med. 168, 1271±1291.Mowiol (Hoechst, Frankfurt, Germany) containing 1,4-diazabicyclo-
2,2,2-octane (DABCO, Sigma) as an antifading reagent. All second- Havell, E.A. (1993). Listeria monocytogenes-induced interferon-g
ary antibodies were from Dianova (Hamburg) and diluted in PBS/ primes the host for production of tumor necrosis factor and inter-
0.1% bovine serum albumin/1% saponin. The slides were examined feron-a/b. J. Infect. Dis. 1993, 1364±1371.
with a confocal microscope (Leica, Bensheim, Germany) equipped Juretic, A., Spagnoli, G.C., von Bremen, K., HoÈ rig, H., Filgueira, L.,
with an argon/krypton laser (laser lines of 488 nm [for DTAF] and LuÈ scher, U., Babst, R., Harder, F., andHeberer, M. (1994). Generation
568 nm [for LRSC]) and dual detectors for simultaneous scanning of lymphokine-activated killer activity in rodents but not in humans
of two different fluorochromes using the Leica TCS NT software. is nitric oxide dependent. Cell. Immunol. 157, 462±477.
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